Area of research
Dermatology · Surgery
Research interest
Research interests include Hidradenitis Suppurativa and Treatments, Acne and Rosacea Treatments and Effects, Colorectal and Anal Carcinomas, and Anorectal Disease Treatments and Outcomes.
Prevalence of Hidradenitis Suppurativa
Bimekizumab demonstrated a favorable safety profile and high levels of efficacy with up to 2 years of treatment in patients with moderate to severe hidradenitis suppurativa: Pooled results from two phase 3 randomized, controlled trials and their open-label extension
Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa
European S2k guidelines for hidradenitis suppurativa/acne inversa part 2: Treatment
The Global Hidradenitis Suppurativa Atlas Methodology: Combining Global Proportions in a Pooled Analysis
New insights on hidradenitis suppurativa phenotypes and treatment response: An exploratory automated analysis of the <scp>SUNSHINE</scp> and <scp>SUNRISE</scp> trials
Quality of life measurement in urticaria: Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient‐Oriented Outcomes and Urticaria and Angioedema
Quality of life measurement in assessing treatment effectiveness in urticaria: European experts position statement
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials
Hidradenitis suppurativa: new insights into disease mechanisms and an evolving treatment landscape
Variants at the Interleukin 1 Gene Locus and Pericarditis
Genetic variants associated with syncope implicate neural and autonomic processes
Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice
The sequences of 150,119 genomes in the UK Biobank
Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset
Rare SLC13A1 variants associate with intervertebral disc disorder highlighting role of sulfate in disc pathology
Factors associated with treatment satisfaction in patients with hidradenitis suppurativa: results from the Global VOICE project
Methylated <scp>miRNAs</scp><i>may</i> serve as potential biomarkers and therapeutic targets for hidradenitis suppurativa
Registries, multicentre and genome‐wide association studies in hidradenitis suppurativa
A genome-wide meta-analysis yields 46 new loci associating with biomarkers of iron homeostasis
Efficacy and Safety of Adalimumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa
The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study
Anti‐COVID‐19 measurements for hidradenitis suppurativa patients
Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life
What causes hidradenitis suppurativa ?—15 years after
Medical and Surgical Management of Hidradenitis Suppurativa: A Review of International Treatment Guidelines and Implementation in General Dermatology Practice
Clinical characteristics of pediatric hidradenitis suppurativa: a cross-sectional multicenter study of 140 patients
Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project
Cutaneous candidiasis – an evidence‐based review of topical and systemic treatments to inform clinical practice